Literature DB >> 19268553

Gamma irradiation alters the phenotype and function of CD4+CD25+ regulatory T cells.

Mengde Cao1, Roniel Cabrera, Yiling Xu, Chen Liu, David Nelson.   

Abstract

To examine the effects of gamma irradiation on Tregs, changes in phenotype and suppression function in Tregs treated with or without gamma ray were analyzed. Purified CD4(+)CD25(+) regulatory T cells were irradiated at different dosages with a (137)Cs source gamma ray at 4.8 Gy/min. After culture, the phenotype and function changes were determined by flow cytometry and [(3)H]-thymidine incorporation, respectively. A dose-dependent reduction of Tregs proliferation in response to gamma irradiation was noted, which paralleled the apoptosis induction of Tregs. Gamma irradiation downregulated the Tregs expression of CD45RO, CD62L, FOXP3, membrane TGF-beta, but upregulated Bax and GITR. High dose gamma irradiation (30 Gy) significantly abolished the suppression of Tregs on CD4(+)CD25(-) T cells proliferation. Thus Tregs not only influences the phenotype but also alters their suppressive capacities. Our findings suggest that radiotherapy may be an important strategy to alter the immunologic balance of Tregs and effector cells in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268553      PMCID: PMC2683182          DOI: 10.1016/j.cellbi.2009.02.007

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  33 in total

1.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

2.  Differential induction from X-irradiated human peripheral blood monocytes to dendritic cells.

Authors:  Hironori Yoshino; Kenji Takahashi; Satoru Monzen; Ikuo Kashiwakura
Journal:  J Radiat Res       Date:  2008-03-14       Impact factor: 2.724

3.  Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes.

Authors:  Hiroshi Tanaka; Junta Tanaka; Jørgen Kjaergaard; Suyu Shu
Journal:  J Immunother       Date:  2002 May-Jun       Impact factor: 4.456

4.  Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

Authors:  J Shimizu; S Yamazaki; S Sakaguchi
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

5.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 6.  Immune modulation by ionizing radiation and its implications for cancer immunotherapy.

Authors:  Eric J Friedman
Journal:  Curr Pharm Des       Date:  2002       Impact factor: 3.116

7.  Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.

Authors:  Jiali Li; Peisheng Hu; Leslie A Khawli; Alan L Epstein
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

8.  Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice.

Authors:  Emma Jones; Michaela Dahm-Vicker; Anna Katharina Simon; Angharad Green; Fiona Powrie; Vincenzo Cerundolo; Awen Gallimore
Journal:  Cancer Immun       Date:  2002-02-22

9.  TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice.

Authors:  Kazuhiko Nakamura; Atsushi Kitani; Ivan Fuss; Aasta Pedersen; Naohiko Harada; Hajime Nawata; Warren Strober
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 10.  TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression.

Authors:  WanJun Chen; Sharon M Wahl
Journal:  Cytokine Growth Factor Rev       Date:  2003-04       Impact factor: 7.638

View more
  25 in total

1.  2-Gy whole-body irradiation significantly alters the balance of CD4+ CD25- T effector cells and CD4+ CD25+ Foxp3+ T regulatory cells in mice.

Authors:  Yanyan Qu; Baojun Zhang; Shuchun Liu; Aijun Zhang; Tingting Wu; Yong Zhao
Journal:  Cell Mol Immunol       Date:  2010-09-27       Impact factor: 11.530

Review 2.  The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.

Authors:  Miles Piper; Adam C Mueller; Sana D Karam
Journal:  Mol Carcinog       Date:  2020-05-04       Impact factor: 4.784

Review 3.  Immune recognition of irradiated cancer cells.

Authors:  Erik Wennerberg; Claire Vanpouille-Box; Sophia Bornstein; Takahiro Yamazaki; Sandra Demaria; Lorenzo Galluzzi
Journal:  Immunol Rev       Date:  2017-11       Impact factor: 12.988

4.  A Pilot Feasibility Study of Yttrium-90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases.

Authors:  Chongkai Wang; John Park; Ching Ouyang; Jeff A Longmate; Michael Tajon; Joseph Chao; Dean Lim; Jaideep Sandhu; Hongwei Holly Yin; Raju Pillai; Maricel C Gozo; Christian Avalos; Colt A Egelston; Peter P Lee; Marwan Fakih
Journal:  Oncologist       Date:  2019-12-19

Review 5.  Immunomodulatory effects of radiation: what is next for cancer therapy?

Authors:  Anita Kumari; Samantha S Simon; Tomika D Moody; Charlie Garnett-Benson
Journal:  Future Oncol       Date:  2015-12-01       Impact factor: 3.404

6.  A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

Authors:  Susan M Hiniker; Daniel S Chen; Sunil Reddy; Daniel T Chang; Jennifer C Jones; Joseph A Mollick; Susan M Swetter; Susan J Knox
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

7.  Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice.

Authors:  Shuang Wei; Martin U Egenti; Seagal Teitz-Tennenbaum; Weiping Zou; Alfred E Chang
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

8.  Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.

Authors:  Ayman J Oweida; Adam C Mueller; Miles Piper; Dallin Milner; Benjamin Van Court; Shilpa Bhatia; Andy Phan; Thomas Bickett; Kimberly Jordan; Theresa Proia; Richard Schulick; Wells A Messersmith; Marco Del Chiaro; Eric Clambey; Michael J Gough; Jason Williams; Kirk Hansen; Karyn Goodman; Sana D Karam
Journal:  Cancer Immunol Immunother       Date:  2020-10-23       Impact factor: 6.968

Review 9.  Cytokines in radiobiological responses: a review.

Authors:  Dörthe Schaue; Evelyn L Kachikwu; William H McBride
Journal:  Radiat Res       Date:  2012-10-29       Impact factor: 2.841

Review 10.  Effects of radiation on T regulatory cells in normal states and cancer: mechanisms and clinical implications.

Authors:  Shu Liu; Xiangdong Sun; Jinhua Luo; Hongcheng Zhu; Xi Yang; Qing Guo; Yaqi Song; Xinchen Sun
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.